{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:41:12Z","timestamp":1762875672806,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,5,31]],"date-time":"2015-05-31T00:00:00Z","timestamp":1433030400000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.6061\/clinics\/2015(05)03","type":"journal-article","created":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T04:13:41Z","timestamp":1433391221000},"page":"322-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Low educational level but not low income impairs the achievement of cytogenetic remission in chronic myeloid leukemia patients treated with imatinib in Brazil"],"prefix":"10.1016","volume":"70","author":[{"given":"Monica Napole\u00e3o Fortes","family":"Rego","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konradin","family":"Metze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Lorand-Metze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.6061\/clinics\/2015(05)03_bib1","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1182\/blood-2010-03-273979","article-title":"Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)","volume":"116","author":"Hughes","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.6061\/clinics\/2015(05)03_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1756-8722-6-70","article-title":"GEKID Cancer Survival Working Group. Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century","volume":"6","author":"Pulte","year":"2013","journal-title":"J Hematol Oncol"},{"key":"10.6061\/clinics\/2015(05)03_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004266","article-title":"Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort","volume":"4","author":"Smith","year":"2014","journal-title":"BMJ Open"},{"issue":"2","key":"10.6061\/clinics\/2015(05)03_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/0284186X.2013.865079","article-title":"Implications of patients\u2019 socioeconomic status - what oncologists should be aware of","volume":"53","author":"Cavalli-Bj\u00f6rkman","year":"2014","journal-title":"Acta Oncol"},{"issue":"2","key":"10.6061\/clinics\/2015(05)03_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/0284186X.2013.844353","article-title":"Adherence and patients\u2019 experiences with the use of oral anticancer agents","volume":"53","author":"Timmers","year":"2014","journal-title":"Acta Oncol"},{"key":"10.6061\/clinics\/2015(05)03_bib6","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Portaria SAS n\u00b0 347 de 23 de junho de 2008, Protocolo e Diretrizes Terap\u00eauticas para o tratamento da Leucemia Mieloide Cr\u00f4nica. Di\u00e1rio Oficial da Uni\u00e3o, n\u00b0 120, de 25 de julho de 2008, se\u00e7\u00e3o 1, p\u00e1gina 54. Bras\u00edlia; 2008."},{"key":"10.6061\/clinics\/2015(05)03_bib7","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Portaria SAS n\u00b0 1219 de 14 de novembro de 2013, Protocolo e Diretrizes Terap\u00eauticas para o tratamento da Leucemia Mieloide Cr\u00f4nica. Di\u00e1rio Oficial da Uni\u00e3o, de 15 de mar\u00e7o de 2013, se\u00e7\u00e3o 1, p\u00e1gina 45-52. Bras\u00edlia; 2013."},{"issue":"4","key":"10.6061\/clinics\/2015(05)03_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000339696","article-title":"Evaluation of long-term outcomes, cytogenetic and molecular responses with imatinib mesylate in early and late chronic-phase chronic myeloid leukemia: a report from a single institute","volume":"128","author":"Bendit","year":"2012","journal-title":"Acta Haematol"},{"issue":"4","key":"10.6061\/clinics\/2015(05)03_bib9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V63.4.789.789","article-title":"Prognostic discrimination in good-risk chronic granulocytic leukemia","volume":"63","author":"Sokal","year":"1984","journal-title":"Blood"},{"issue":"11","key":"10.6061\/clinics\/2015(05)03_bib10","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jnci\/90.11.850","article-title":"A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group","volume":"90","author":"Hasford","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.6061\/clinics\/2015(05)03_bib11","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1182\/blood-2010-12-319038","article-title":"Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: EUTOS score","volume":"118","author":"Hasford","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.6061\/clinics\/2015(05)03_bib12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.6061\/clinics\/2015(05)03_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/annonc\/mdq201","article-title":"ESMO Guidelines Working Group. Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Baccarani","year":"2010","journal-title":"Ann Oncol"},{"key":"10.6061\/clinics\/2015(05)03_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/1471-2407-10-260","article-title":"Fractal dimension is an independent prognostic factor for survival in melanoma","volume":"10","author":"Bedin","year":"2010","journal-title":"BMC Cancer"},{"issue":"6","key":"10.6061\/clinics\/2015(05)03_bib15","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.3109\/10428194.2010.527402","article-title":"Polymorphisms of glutathione S-transferase mu 1, theta 1 and pi 1 genes and prognosis in Hodgkin lymphoma","volume":"50","author":"Louren\u00e7o","year":"2010","journal-title":"Leuk & Lymph"},{"issue":"6","key":"10.6061\/clinics\/2015(05)03_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020706","article-title":"Fractal Characteristics of May-Gr\u00fcnwald-Giemsa stained Chromatin are Independent Prognostic Factors for Survival in Multiple Myeloma","volume":"6","author":"Ferro","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"10.6061\/clinics\/2015(05)03_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081048","article-title":"Immunophenotyping in myelodysplastic syndromes can add prognostic information to well-established and new clinical scores","volume":"8","author":"Reis-Alves","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.6061\/clinics\/2015(05)03_bib18","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3109\/10428194.2011.653641","article-title":"First-line treatment with imatinib mesylate in patients with chronic phase chronic myeloid leukemia: experience of a public hospital in a developing country of South America","volume":"53","author":"Silveira","year":"2012","journal-title":"Leuk & Lymphoma"},{"issue":"1","key":"10.6061\/clinics\/2015(05)03_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000345722","article-title":"Adherence to tyrosine kinase inhibitor therapy for chronic myeloid leukemia: A Brazilian single-center cohort","volume":"130","author":"de Almeida","year":"2013","journal-title":"Acta Haematol"},{"issue":"7","key":"10.6061\/clinics\/2015(05)03_bib20","doi-asserted-by":"crossref","first-page":"731","DOI":"10.6061\/clinics\/2012(07)05","article-title":"Disparities in female breast cancer mortality rates in Brazil between 1980 and 2009","volume":"67","author":"Freitas-Junior","year":"2012","journal-title":"Clinics"},{"issue":"7","key":"10.6061\/clinics\/2015(05)03_bib21","doi-asserted-by":"crossref","first-page":"915","DOI":"10.6061\/clinics\/2013(07)05","article-title":"Cognition, behavior and social competence of preterm low birth weight children at school age","volume":"68","author":"Fan","year":"2013","journal-title":"Clinics"},{"issue":"10","key":"10.6061\/clinics\/2015(05)03_bib22","first-page":"481","article-title":"Compliance with chemotherapy in childhood leukaemia in Africa","volume":"75","author":"MacDougall","year":"1989","journal-title":"S Afr Med J"},{"issue":"8","key":"10.6061\/clinics\/2015(05)03_bib23","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/ijc.26186","article-title":"Mortality after childhood cancer dependent on social or economic resources of parents? A population-based study","volume":"130","author":"Syse","year":"2012","journal-title":"Int J Cancer"},{"issue":"2","key":"10.6061\/clinics\/2015(05)03_bib24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejca.2011.10.007","article-title":"Survival from childhood acute lymphoblastic leukaemia: the impact of social inequality in the United Kingdom","volume":"48","author":"Lightfoot","year":"2012","journal-title":"Eur J Cancer"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222013795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222013795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-70-5\/cln-70-05-322.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:02:26Z","timestamp":1761721346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222013795"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322015000500322&lng=en&nrm=iso","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4449460\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1807593222013795"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2015(05)03","relation":{},"ISSN":["1807-5932"],"issn-type":[{"type":"print","value":"1807-5932"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low educational level but not low income impairs the achievement of cytogenetic remission in chronic myeloid leukemia patients treated with imatinib in Brazil","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2015(05)03","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}